GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Australian Clinical Labs Ltd (ASX:ACL) » Definitions » Current Deferred Revenue

Australian Clinical Labs (ASX:ACL) Current Deferred Revenue : A$0.0 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Australian Clinical Labs Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Australian Clinical Labs's current deferred revenue for the quarter that ended in Dec. 2023 was A$0.0 Mil.

Australian Clinical Labs Current Deferred Revenue Historical Data

The historical data trend for Australian Clinical Labs's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Australian Clinical Labs Current Deferred Revenue Chart

Australian Clinical Labs Annual Data
Trend Dec20 Jun21 Jun22 Jun23
Current Deferred Revenue
- - - -

Australian Clinical Labs Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Current Deferred Revenue Get a 7-Day Free Trial - - - - -

Australian Clinical Labs Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Australian Clinical Labs's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Australian Clinical Labs (ASX:ACL) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Australian Clinical Labs Ltd (ASX:ACL) » Definitions » Current Deferred Revenue
Comparable Companies
ASX:MVF ASX:IDX ASX:MAP ASX:GSS ASX:IIQ ASX:RHY ASX:HLS ASX:LDX ASX:CTE ASX:GTG TMO DHR SHSE:603259 IQV IDXX A XSWX:LONN MTD ICLR LH
Traded in Other Exchanges
N/A
Address
1868-1892 Dandenong Road, Clayton, VIC, AUS, 3168
Website
https://www.clinicallabs.com.au
Australian Clinical Labs, or ACL, is Australia's third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well-established in the states of Western Australia, South Australia, Victoria and the Northern Territory.

Australian Clinical Labs (ASX:ACL) Headlines

No Headlines